Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment.
Kreuter M, Kropff M, Fischaleck A, Junker K, Gerss J, Heinecke A, Lindermann M, Reinmuth N, Berdel WE, Mesters RM, Thomas M.
Kreuter M, et al.
Eur Respir J. 2009 Jun;33(6):1383-8. doi: 10.1183/09031936.00121108. Epub 2009 Feb 12.
Eur Respir J. 2009.
PMID: 19213790
Free article.
Clinical Trial.